语言版本

Time of issue:2021-09-02 16:56:33
搜索
Search
/
Product
All categories
Number of views:
1000
Keywords:
FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Number of views:
1000
Keywords:
treatment
disease
indicated
metastatic
in
for
progression
is
faslodex
Nintedanib esylate is a small molecule tyrosine kinase inhibitor with antifibrotic and anti-inflammatory activities for the treatment of idiopathic pulmonary fibrosis.
Number of views:
1000
Keywords:
small
treatment
for
pulmonary
is
the
with
fibrosis.
kinase
Ruxolitinib phosphate is indicated for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis (PMF) (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis (PPV-MF), orpost-essential thrombocythemia myelofibrosis (PET-MF).
Number of views:
1000
Keywords:
myelofibrosis
known
Bendamustine HCl was originally manufactured in East Germany (former German Democratic Republic) in 1963.
Number of views:
1000
Keywords:
Bendamustine
treatment
Olopatadine HCl was developed by Kyowa Hakko Kirin, and it was first approved by the FOOD and Drug Administration (FDA) of the United States on December 18, 1996,
Number of views:
1000
Keywords:
Olopatadine
Patanol
Previous page
1

RELATED WEBSITES

友情链接

Time of issue:2020-07-27 00:00:00
Online customer service
Customer service hotline
+86-023-67886928 +86-023-67886928
Service time:
8:30 - 17:30
Customer service group:
在线客服

地址版权

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved.  渝ICP备2021007919号  1渝公网安备50011702500758号  Powered by:www.300.cn

地址版权手机

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd.

渝ICP备2021007919号  Powered by:www.300.cn

1渝公网安备50011702500758号